These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2508593

  • 21. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS, Pierangeli A.
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [Abstract] [Full Text] [Related]

  • 22. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB.
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [Abstract] [Full Text] [Related]

  • 23. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy].
    Rosenbaum M, Posse R, Sgammini H, Núñez Burgos J, Chiale PA, Pastori JD, González Zuelgaray J, Brunetto JF, Califano JE.
    Arch Inst Cardiol Mex; 1987 May; 57(4):325-30. PubMed ID: 2445316
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 25. [Continuous ventricular tachyarrhythmia in patients without detectable organic heart disease: clinical and electrophysiologic findings].
    Schöls W, Brachmann J, Schmitt C, Waldecker B, Kübler W.
    Z Kardiol; 1989 Dec; 78(12):790-6. PubMed ID: 2623922
    [Abstract] [Full Text] [Related]

  • 26. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F, Santarelli P, Montenero S, Nobile A, Spampinato A, Nava S, Zecchi P, Manzoli U.
    Cardiologia; 1988 Apr; 33(4):399-405. PubMed ID: 3409264
    [No Abstract] [Full Text] [Related]

  • 27. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, Oudijk MA, Meijboom EJ, Feinkind L, Hussey M, Parilla BV.
    Circulation; 2004 Jan 27; 109(3):375-9. PubMed ID: 14732753
    [Abstract] [Full Text] [Related]

  • 28. [Value of beta blockers in the treatment of recurrent ventricular tachycardia in cardiac insufficiency].
    Hermida JS, Coumel P, Leclercq JF, Cauchemez B, Maison-Blanche P, Leenhardt A, Slama R.
    Arch Mal Coeur Vaiss; 1987 Mar 27; 80(3):290-300. PubMed ID: 2887146
    [Abstract] [Full Text] [Related]

  • 29. [Life expectancy after a first attack of sustained monomorphic ventricular tachycardia. Apropos of 295 patients with a follow-up of more than 5 years].
    Leclercq JF, Leenhardt A, Ruta I, Cauchemez B, Chouty F, Denjoy I, Maison-Blanche P, Coumel P, Slama R.
    Arch Mal Coeur Vaiss; 1991 Dec 27; 84(12):1789-96. PubMed ID: 1793315
    [Abstract] [Full Text] [Related]

  • 30. Electropharmacological test with pentisomide (CM 7857) in patients with sustained ventricular tachycardia.
    Vergara G, Inama G, Guarnerio M, Rando F, Oldani V, Furlanello F.
    G Ital Cardiol; 1990 Jun 27; 20(6):543-8. PubMed ID: 2227224
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of resistant ventricular tachycardia with endocavitary ablation combined with anti-arrhythmia agents].
    Fontaine G, Tonet JL, Frank R, Touzet I, Farenq G, Dubois-Rande JL, Baraka M, Abdelali S, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1986 Jul 27; 79(8):1152-9. PubMed ID: 3096239
    [Abstract] [Full Text] [Related]

  • 32. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct 27; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

  • 33. [Effects of flecainide in patients with non-sustained ventricular tachycardia and impaired left ventricular function].
    De Marzio P, Morelli S, Suppa M, Caputo V, Mango L, Guido V, Cardoni F, Gnecchi M, Aguglia F.
    Minerva Cardioangiol; 1991 Oct 27; 39(1-2):35-9. PubMed ID: 1906997
    [Abstract] [Full Text] [Related]

  • 34. Long-term results of amiodarone therapy.
    Herre JM, Sauve MJ, Scheinman MM.
    Clin Cardiol; 1987 Jul 27; 10(7 Suppl 1):I21-5. PubMed ID: 3271187
    [Abstract] [Full Text] [Related]

  • 35. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D, Eydt JN.
    CMAJ; 1986 Mar 01; 134(5):495-501. PubMed ID: 3948063
    [Abstract] [Full Text] [Related]

  • 36. [Arrhythmologic study of 50 patients with arrhythmogenic disease of the right ventricle: prognostic implications].
    Bettini R, Furlanello F, Vergara G, Durante G, Bertoldi A, Visonà L, Dal Forno P, Camin G, Burelli C, Nicolosi GL.
    G Ital Cardiol; 1989 Jul 01; 19(7):567-79. PubMed ID: 2806788
    [Abstract] [Full Text] [Related]

  • 37. [Incessant idiopathic ventricular tachycardia in infants].
    Villain E, Bonnet D, Kachaner J, Le Bidois J, Cohen L, Piéchaud JF, Sidi D.
    Arch Mal Coeur Vaiss; 1990 May 01; 83(5):665-71. PubMed ID: 2114081
    [Abstract] [Full Text] [Related]

  • 38. [Prognosis of ventricular tachycardia].
    Djiane P, Tafani C, Bonnet JL, Villain P, Habib G, Bory M, Serradimigni A.
    Arch Mal Coeur Vaiss; 1988 Oct 01; 81(10):1167-72. PubMed ID: 3146954
    [Abstract] [Full Text] [Related]

  • 39. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
    Rea RS, Kane-Gill SL, Rudis MI, Seybert AL, Oyen LJ, Ou NN, Stauss JL, Kirisci L, Idrees U, Henderson SO.
    Crit Care Med; 2006 Jun 01; 34(6):1617-23. PubMed ID: 16614583
    [Abstract] [Full Text] [Related]

  • 40. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P, De Ponti R, Uriarte JA, Tondo C, Klersy C, Carbucicchio C, Storti C, Riva S, Longobardi M.
    Eur Heart J; 2002 Mar 01; 23(5):414-24. PubMed ID: 11846499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.